Grass Pollen Allergy

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Grass Pollen Allergy trials you may qualify for

100

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 4 trials

RecruitingNot Applicable

NCT07055542

Creating A Risk Assessment Tool for Thunderstorm Asthma: the CARISTA Study

Thunderstorm asthma is a recurring public health emergency in South-Eastern Australia which occurs in springtime. The major identified risk factors for thunders…

Australia530 participantsStarted 2025-08-27

Treatment: Observational

RecruitingNot Applicable

NCT07419230

Evaluation of a Digital Tool to Improve Aeroallergen Immunotherapy Adherence. NavigAITme Project

Aaeroallergen Immunotherapy (AIT) is indicated in the treatment of allergic rhinitis and asthma, and has shown efficacy to control symptoms and induce immunomod…

Spain880 participantsStarted 2026-03-11

Treatment: Active Adherence-booster App, Inactive Adherence-booster App

RecruitingNot Applicable

NCT07412990

GRASS (Grass MATA MPL Real-world Assessment Study)

Objective of this non-interventional study (NIS) is to collect data on the use of Grassmuno® in routine clinical practice.

Germany1,000 participantsStarted 2026-03-11

Treatment: Grassmuno®

RecruitingPhase 3

NCT04891237

Efficacy and Safety Evaluation for the Treatment of Allergy Against Grass and Olive Pollen

Prospective, multicenter, randomized, double-blind, placebo-controlled clinical trial of efficacy and safety with subcutaneous immunotherapy in patients with mi…

Spain180 participantsStarted 2021-06-14

Treatment: 10,000 MG01 + 10,000 T517, 30,000 MG01 + 10,000 T517

All recent trials (100 shown)

CompletedPhase 2/3

NCT04687059

An Exploratory Study of PQ Grass 27600 SU

PQGrass309 is aimed at exploring the expected average treatment effect of PQ Grass 27600 SU cumulative dose on symptom and medication score in a field setting.…

United States119 participantsStarted 2020-10-19

Treatment: PQ Grass, Active Placebo

CompletedPhase 2

NCT04502966

Grass Pollen Immunotherapy Plus Dupilumab for Tolerance Induction

The primary objective of this study is to assess whether the combination of grass allergen sublingual immunotherapy (SLIT) and dupilumab for 2 years is more eff…

United Kingdom199 participantsStarted 2020-11-05

Treatment: Dupixent®, Grazax®

Grass Pollen Allergy

Trial phase breakdown

Trial status

Actively recruiting — 4 trials

Creating A Risk Assessment Tool for Thunderstorm Asthma: the CARISTA Study

Evaluation of a Digital Tool to Improve Aeroallergen Immunotherapy Adherence. NavigAITme Project

GRASS (Grass MATA MPL Real-world Assessment Study)

Efficacy and Safety Evaluation for the Treatment of Allergy Against Grass and Olive Pollen

All recent trials (100 shown)

An Exploratory Study of PQ Grass 27600 SU

Grass Pollen Immunotherapy Plus Dupilumab for Tolerance Induction

Trial phase breakdown

Trial status

Actively recruiting — 4 trials

Creating A Risk Assessment Tool for Thunderstorm Asthma: the CARISTA Study

Evaluation of a Digital Tool to Improve Aeroallergen Immunotherapy Adherence. NavigAITme Project

GRASS (Grass MATA MPL Real-world Assessment Study)

Efficacy and Safety Evaluation for the Treatment of Allergy Against Grass and Olive Pollen

All recent trials (100 shown)

An Exploratory Study of PQ Grass 27600 SU

Grass Pollen Immunotherapy Plus Dupilumab for Tolerance Induction

M-Gard Particulate EW Efficacy Study on Seasonal Allergic Rhinitis

Tyrosine Allergoid Paediatric and Adult Study

Evaluation of Grass Pollen Sensitization Among Professionals Exposed or Not Exposed to Flour

Documentation of Efficacy of Intralymphatic Allergen Immunotherapy

A Motivation-enhancing App to Retain Patients With Hay Fever in a Trial After Treatment

Intralymphatic Immunotherapy With Polvac Grass & Rye Allergen Extract

Efficacy and Safety of PQ Grass in Subjects With Seasonal Allergic Rhinitis and/or Rhinoconjunctivitis Induced by Grass…

A Study in Adults With Grass Pollen-induced Rhinoconjunctivitis

Tolerability of Grazax in Patients With Hayfever in Real Life Settings

Factors Predicting Efficacy of Allergen Injection Immunotherapy for Grass Pollen Hayfever

Revaccination With Pollinex® Quattro

Efficacy and Safety Evaluation for the Treatment of Asthma and Allergic Rhinitis/Rhinoconjunctivitis

A Safety and Activity Study of NS2 in Subjects With Allergic Conjunctivitis

Determination of Grass Pollen Allergen Concentration Inducing Rhinoconjunctivitis Symptoms in Subjects Allergic to Grass…

The Effects of OC000459 on Nasal Mediators

Grass Pollen Immunotherapy Using a Cluster Regime for Seasonal Rhinitis and Asthma

Repeat Nasal Allergen Challenge

Safety of Bronchial Allergen Challenge and Predictors for Positive Reaction.